{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T10:42:09Z","timestamp":1773052929464,"version":"3.50.1"},"reference-count":91,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T00:00:00Z","timestamp":1732579200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"M. Schickedanz Kinderkrebsstiftung"},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["500215849"],"award-info":[{"award-number":["500215849"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["PI 405\/15"],"award-info":[{"award-number":["PI 405\/15"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005677","name":"Jos\u00e9 Carreras Leuk\u00e4mie-Stiftung","doi-asserted-by":"publisher","award":["DJCLS 10 R\/2024"],"award-info":[{"award-number":["DJCLS 10 R\/2024"]}],"id":[{"id":"10.13039\/501100005677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004189","name":"Max-Planck-Gesellschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004189","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosbiology.org"],"crossmark-restriction":false},"short-container-title":["PLoS Biol"],"abstract":"<jats:p>Excessive cytokine signaling resulting from dysregulation of a cytokine or its receptor can be a main driver of cancer, autoimmune, or hematopoietic disorders. Here, we leverage protein design to create tailored cytokine receptor blockers with idealized properties. Specifically, we aimed to tackle the granulocyte-colony stimulating factor receptor (G-CSFR), a mediator of different types of leukemia and autoinflammatory diseases. By modifying designed G-CSFR binders, we engineered hyper-stable proteins that function as nanomolar signaling antagonists. X-ray crystallography showed atomic-level agreement with the experimental structure of an exemplary design. Furthermore, the most potent design blocks G-CSFR in acute myeloid leukemia cells and primary human hematopoietic stem cells. Thus, the resulting designs can be used for inhibiting or homing to G-CSFR-expressing cells. Our results also demonstrate that similarly designed cytokine mimics can be used to derive antagonists to tackle other type I cytokine receptors.<\/jats:p>","DOI":"10.1371\/journal.pbio.3002883","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T22:44:29Z","timestamp":1732661069000},"page":"e3002883","update-policy":"https:\/\/doi.org\/10.1371\/journal.pbio.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["A strategy to design protein-based antagonists against type I cytokine receptors"],"prefix":"10.1371","volume":"22","author":[{"given":"Timo","family":"Ullrich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Klimenkova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Pollmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asma","family":"Lasram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeriia","family":"Hatskovska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kateryna","family":"Maksymenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matej","family":"Milija\u0161-Joti\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lukas","family":"Schenk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Lengerke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus D.","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Piehler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Skokowa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3446-8774","authenticated-orcid":true,"given":"Mohammad","family":"ElGamacy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2024,11,26]]},"reference":[{"key":"pbio.3002883.ref001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2009.05382.x","article-title":"An overview of cytokines and cytokine antagonists as therapeutic agents","volume":"1182","author":"RP Donnelly","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"pbio.3002883.ref002","article-title":"Infliximab: A Review of Its Use in the Treatment of Inflammatory Bowel Disease","volume":"3","author":"M Marzo","year":"2011","journal-title":"Clin Med Insights Ther"},{"issue":"1","key":"pbio.3002883.ref003","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2165\/00063030-200923010-00006","article-title":"Ustekinumab","volume":"23","author":"J Weber","year":"2009","journal-title":"BioDrugs"},{"issue":"7","key":"pbio.3002883.ref004","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1053\/j.gastro.2021.02.062","article-title":"Therapeutic Interleukin-6 Trans-signaling Inhibition by Olamkicept (sgp130Fc) in Patients With Active Inflammatory Bowel Disease","volume":"160","author":"S Schreiber","year":"2021","journal-title":"Gastroenterology"},{"issue":"12","key":"pbio.3002883.ref005","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s40265-014-0258-9","article-title":"Etanercept: a review of its use in autoimmune inflammatory diseases","volume":"74","author":"LJ Scott","year":"2014","journal-title":"Drugs"},{"issue":"01","key":"pbio.3002883.ref006","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1136\/ard.2008.105197","article-title":"Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study","volume":"69","author":"G Jones","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"null","key":"pbio.3002883.ref007","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2147\/DDDT.S100302","article-title":"Profile of sarilumab and its potential in the treatment of rheumatoid arthritis","volume":"11","author":"MG Raimondo","year":"2017","journal-title":"Drug Des Devel Ther"},{"issue":"6","key":"pbio.3002883.ref008","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1084\/jem.178.6.2213","article-title":"An interleukin 4 (IL-4) mutant protein inhibits both IL-4 or IL-13-induced human immunoglobulin G4 (IgG4) and IgE synthesis and B cell proliferation: support for a common component shared by IL-4 and IL-13 receptors","volume":"178","author":"G Aversa","year":"1993","journal-title":"J Exp Med"},{"issue":"2","key":"pbio.3002883.ref009","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1517\/14712598.1.2.301","article-title":"Interleukin-1 receptor antagonist as therapy for inflammatory disorders","volume":"1","author":"BD Freeman","year":"2001","journal-title":"Expert Opin Biol Ther"},{"issue":"11","key":"pbio.3002883.ref010","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s41580-019-0163-x","article-title":"Advances in protein structure prediction and design","volume":"20","author":"B Kuhlman","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"pbio.3002883.ref011","first-page":"85","volume-title":"Advances in Protein Chemistry and Structural Biology","author":"M. ElGamacy","year":"2022"},{"key":"pbio.3002883.ref012","article-title":"A review of granulocyte colony-stimulating factor receptor signaling and regulation with implications for cancer","volume":"12","author":"SD Park","year":"2022","journal-title":"Frontiers in Oncology"},{"key":"pbio.3002883.ref013","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.exphem.2016.10.008","article-title":"Granulocyte colony-stimulating factor receptor signaling in severe congenital neutropenia, chronic neutrophilic leukemia, and related malignancies","volume":"46","author":"P Dwivedi","year":"2017","journal-title":"Exp Hematol"},{"issue":"4","key":"pbio.3002883.ref014","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cytogfr.2014.07.011","article-title":"G-CSF: From granulopoietic stimulant to bone marrow stem cell mobilizing agent","volume":"25","author":"LJ Bendall","year":"2014","journal-title":"Cytokine Growth Factor Rev"},{"issue":"8","key":"pbio.3002883.ref015","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1172\/JCI23559","article-title":"The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis","volume":"115","author":"A Schneider","year":"2005","journal-title":"J Clin Invest"},{"key":"pbio.3002883.ref016","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3389\/fcell.2015.00048","article-title":"The granulocyte-colony stimulating factor has a dual role in neuronal and vascular plasticity","volume":"3","author":"S Wallner","year":"2015","journal-title":"Front Cell Dev Biol"},{"issue":"6206","key":"pbio.3002883.ref017","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/337471a0","article-title":"Granulocyte- and granulocyte-macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate","volume":"337","author":"F Bussolino","year":"1989","journal-title":"Nature"},{"issue":"3","key":"pbio.3002883.ref018","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nm1199","article-title":"G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes","volume":"11","author":"M Harada","year":"2005","journal-title":"Nat Med"},{"key":"pbio.3002883.ref019","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fonc.2014.00093","article-title":"Granulocyte colony-stimulating factor receptor mutations in myeloid malignancy","volume":"4","author":"C Liongue","year":"2014","journal-title":"Front Oncol"},{"issue":"6\u20137","key":"pbio.3002883.ref020","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1349-7006.1990.tb02619.x","article-title":"Granulocyte colony-stimulating factor-dependent growth of an acute myeloblastic leukemia cell line","volume":"81","author":"N Nara","year":"1990","journal-title":"Jpn J Cancer Res"},{"issue":"5","key":"pbio.3002883.ref021","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/bjc.2013.822","article-title":"G-CSF and G-CSFR are highly expressed in human gastric and colon cancers and promote carcinoma cell proliferation and migration","volume":"110","author":"K Morris","year":"2014","journal-title":"Br J Cancer"},{"issue":"1","key":"pbio.3002883.ref022","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/bjc.2013.673","article-title":"Granulocyte colony-stimulating factor receptor signalling via Janus kinase 2\/signal transducer and activator of transcription 3 in ovarian cancer","volume":"110","author":"J Kumar","year":"2014","journal-title":"Br J Cancer"},{"issue":"5","key":"pbio.3002883.ref023","first-page":"2019","article-title":"The role of granulocyte colony-stimulating factor in breast cancer development: a review","volume":"21","author":"L Liu","year":"2020","journal-title":"Mol Med Rep"},{"issue":"4","key":"pbio.3002883.ref024","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/febs.14206","article-title":"Neutrophils, G-CSF and their contribution to breast cancer metastasis","volume":"285","author":"KA Mouchemore","year":"2018","journal-title":"FEBS J"},{"issue":"10","key":"pbio.3002883.ref025","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1038\/bjc.1997.254","article-title":"Granulocyte colony-stimulating factor receptor expression on human transitional cell carcinoma of the bladder","volume":"75","author":"M Tachibana","year":"1997","journal-title":"Br J Cancer"},{"issue":"1","key":"pbio.3002883.ref026","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/nrd.2016.231","article-title":"Anti-colony-stimulating factor therapies for inflammatory and autoimmune diseases","volume":"16","author":"JA Hamilton","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"pbio.3002883.ref027","article-title":"G-CSF\u2013A double edge sword in neutrophil mediated immunity","author":"KR Martin","year":"2021","journal-title":"Semin Immunol"},{"issue":"11","key":"pbio.3002883.ref028","doi-asserted-by":"crossref","first-page":"4392","DOI":"10.4049\/jimmunol.1600121","article-title":"Therapeutic targeting of the G-CSF receptor reduces neutrophil trafficking and joint inflammation in antibody-mediated inflammatory arthritis","volume":"197","author":"IK Campbell","year":"2016","journal-title":"J Immunol"},{"issue":"10","key":"pbio.3002883.ref029","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nrrheum.2009.178","article-title":"G-CSF and GM-CSF as therapeutic targets in rheumatoid arthritis","volume":"5","author":"AL Cornish","year":"2009","journal-title":"Nat Rev Rheumatol"},{"issue":"13","key":"pbio.3002883.ref030","doi-asserted-by":"crossref","first-page":"5193","DOI":"10.1182\/blood-2008-02-139535","article-title":"A key role for G-CSF\u2013induced neutrophil production and trafficking during inflammatory arthritis","volume":"112","author":"JL Eyles","year":"2008","journal-title":"Blood"},{"issue":"1","key":"pbio.3002883.ref031","doi-asserted-by":"crossref","first-page":"2948","DOI":"10.1038\/s41467-022-30157-2","article-title":"A topological refactoring design strategy yields highly stable granulopoietic proteins","volume":"13","author":"J Skokowa","year":"2022","journal-title":"Nat Commun"},{"issue":"9","key":"pbio.3002883.ref032","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1073\/pnas.0511264103","article-title":"Homodimeric cross-over structure of the human granulocyte colony-stimulating factor (GCSF) receptor signaling complex","volume":"103","author":"T Tamada","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7873","key":"pbio.3002883.ref033","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"J Jumper","year":"2021","journal-title":"Nature"},{"key":"pbio.3002883.ref034","article-title":"Tuning of granulopoietic signaling by de novo designed agonists","author":"T Ullrich","year":"2023","journal-title":"bioRxiv"},{"issue":"8016","key":"pbio.3002883.ref035","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","volume":"630","author":"J Abramson","year":"2024","journal-title":"Nature"},{"issue":"1","key":"pbio.3002883.ref036","doi-asserted-by":"crossref","first-page":"4403","DOI":"10.1038\/s41467-019-12301-7","article-title":"The ALFA-tag is a highly versatile tool for nanobody-based bioscience applications","volume":"10","author":"H Gotzke","year":"2019","journal-title":"Nat Commun"},{"issue":"4","key":"pbio.3002883.ref037","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1083\/jcb.201412049","article-title":"Receptor dimerization dynamics as a regulatory valve for plasticity of type I interferon signaling","volume":"209","author":"S Wilmes","year":"2015","journal-title":"J Cell Biol"},{"issue":"6478","key":"pbio.3002883.ref038","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1126\/science.aaw3242","article-title":"Mechanism of homodimeric cytokine receptor activation and dysregulation by oncogenic mutations","volume":"367","author":"S Wilmes","year":"2020","journal-title":"Science"},{"issue":"136","key":"pbio.3002883.ref039","first-page":"e57690","article-title":"Multi-color Localization Microscopy of Single Membrane Proteins in Organelles of Live Mammalian Cells","author":"T Appelhans","year":"2018","journal-title":"JoVE"},{"issue":"2","key":"pbio.3002883.ref040","doi-asserted-by":"crossref","first-page":"100165","DOI":"10.1016\/j.crmeth.2022.100165","article-title":"Four-color single-molecule imaging with engineered tags resolves the molecular architecture of signaling complexes in the plasma membrane","volume":"2","author":"J Sotolongo Bellon","year":"2022","journal-title":"Cell Rep Methods"},{"issue":"17","key":"pbio.3002883.ref041","doi-asserted-by":"crossref","first-page":"8593","DOI":"10.1021\/ac501127r","article-title":"Dynamic submicroscopic signaling zones revealed by pair correlation tracking and localization microscopy","volume":"86","author":"C You","year":"2014","journal-title":"Anal Chem"},{"issue":"8","key":"pbio.3002883.ref042","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/nmeth.1233","article-title":"Dynamic multiple-target tracing to probe spatiotemporal cartography of cell membranes","volume":"5","author":"A Serge","year":"2008","journal-title":"Nat Methods"},{"issue":"4","key":"pbio.3002883.ref043","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1083\/jcb.201709007","article-title":"Single-molecule imaging reveals dynamic biphasic partition of RNA-binding proteins in stress granules","volume":"217","author":"B Niewidok","year":"2018","journal-title":"J Cell Biol"},{"issue":"8","key":"pbio.3002883.ref044","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/nmeth.1237","article-title":"Robust single-particle tracking in live-cell time-lapse sequences","volume":"5","author":"K Jaqaman","year":"2008","journal-title":"Nat Methods"},{"issue":"10","key":"pbio.3002883.ref045","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/j.molcel.2024.03.023","article-title":"Structure of the interleukin-5 receptor complex exemplifies the organizing principle of common beta cytokine signaling","volume":"84","author":"NA Caveney","year":"2024","journal-title":"Mol Cell"},{"issue":"1","key":"pbio.3002883.ref046","doi-asserted-by":"crossref","first-page":"5813","DOI":"10.1038\/s41467-024-49876-9","article-title":"Correlative single-molecule and structured illumination microscopy of fast dynamics at the plasma membrane","volume":"15","author":"H Winkelmann","year":"2024","journal-title":"Nat Commun"},{"issue":"3","key":"pbio.3002883.ref047","doi-asserted-by":"crossref","first-page":"860","DOI":"10.4049\/jimmunol.145.3.860","article-title":"Differentiation of the IL-3-dependent NFS-60 cell line and adaption to growth in macrophage colony-stimulating factor","volume":"145","author":"I Nakoinz","year":"1990","journal-title":"J Immunol (Baltimore, Md: 1950)"},{"issue":"14","key":"pbio.3002883.ref048","doi-asserted-by":"crossref","first-page":"5010","DOI":"10.1073\/pnas.83.14.5010","article-title":"Truncation of the c-myb gene by a retroviral integration in an interleukin 3-dependent myeloid leukemia cell line","volume":"83","author":"Y Weinstein","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"pbio.3002883.ref049","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41592-019-0686-2","article-title":"SciPy 1.0: fundamental algorithms for scientific computing in Python","volume":"17","author":"P Virtanen","year":"2020","journal-title":"Nat Methods"},{"issue":"10","key":"pbio.3002883.ref050","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1182\/blood.V76.10.1962.1962","article-title":"Levels of Serum Granulocyte Colony-Stimulating Factor in Patients With Infections","volume":"76","author":"M Kawakami","year":"1990","journal-title":"Blood"},{"issue":"2","key":"pbio.3002883.ref051","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1107\/S0907444909047337","article-title":"xds","volume":"66","author":"W. Kabsch","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"Pt 1","key":"pbio.3002883.ref052","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1107\/S0907444909042589","article-title":"Molecular replacement with MOLREP","volume":"66","author":"A Vagin","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"4","key":"pbio.3002883.ref053","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1107\/S0907444911001314","article-title":"REFMAC5 for the refinement of macromolecular crystal structures","volume":"67","author":"GN Murshudov","year":"2011","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"Pt 4","key":"pbio.3002883.ref054","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"P Emsley","year":"2010","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"issue":"3","key":"pbio.3002883.ref055","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1006\/jmbi.1993.1626","article-title":"Comparative protein modelling by satisfaction of spatial restraints","volume":"234","author":"A \u0160ali","year":"1993","journal-title":"J Mol Biol"},{"issue":"8","key":"pbio.3002883.ref056","doi-asserted-by":"crossref","first-page":"100560","DOI":"10.1016\/j.crmeth.2023.100560","article-title":"The design of functional proteins using tensorized energy calculations","volume":"3","author":"K Maksymenko","year":"2023","journal-title":"Cell Rep Methods"},{"issue":"9","key":"pbio.3002883.ref057","doi-asserted-by":"crossref","first-page":"e75126","DOI":"10.1371\/journal.pone.0075126","article-title":"Selection of single domain antibodies from immune libraries displayed on the surface of E. coli cells with two \u03b2-domains of opposite topologies","volume":"8","author":"V Salema","year":"2013","journal-title":"PLoS ONE"},{"issue":"1","key":"pbio.3002883.ref058","first-page":"1","article-title":"Room temperature electrocompetent bacterial cells improve DNA transformation and recombineering efficiency","volume":"6","author":"Q Tu","year":"2016","journal-title":"Sci Rep"},{"key":"pbio.3002883.ref059","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.22242.2","article-title":"AlignmentViewer: sequence analysis of large protein families","volume":"9","author":"R Reguant","year":"2020","journal-title":"F1000Res"},{"issue":"9","key":"pbio.3002883.ref060","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1182\/blood.V77.9.2031.2031","article-title":"Establishment of a human acute myeloid leukemia cell line (Kasumi-1) with 8; 21 chromosome translocation","volume":"77","author":"H Asou","year":"1991","journal-title":"Blood"},{"issue":"12","key":"pbio.3002883.ref061","doi-asserted-by":"crossref","first-page":"e3000919","DOI":"10.1371\/journal.pbio.3000919","article-title":"Design of novel granulopoietic proteins by topological rescaffolding","volume":"18","author":"B Hernandez Alvarez","year":"2020","journal-title":"PLoS Biol"},{"issue":"6","key":"pbio.3002883.ref062","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/pro.5560060611","article-title":"Characterization of the receptor binding determinants of granulocyte colony stimulating factor","volume":"6","author":"DC Young","year":"1997","journal-title":"Protein Sci"},{"issue":"11","key":"pbio.3002883.ref063","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1016\/j.bbamcr.2014.05.014","article-title":"Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease","volume":"1843","author":"MD Turner","year":"2014","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"pbio.3002883.ref064","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1111\/bph.12106","article-title":"Exploring avidity: understanding the potential gains in functional affinity and target residence time of bivalent and heterobivalent ligands","volume":"168","author":"G Vauquelin","year":"2013","journal-title":"Br J Pharmacol"},{"issue":"9","key":"pbio.3002883.ref065","doi-asserted-by":"crossref","first-page":"5820","DOI":"10.1074\/jbc.M113.508440","article-title":"Ligand independence of the T618I mutation in the colony-stimulating factor 3 receptor (CSF3R) protein results from loss of O-linked glycosylation and increased receptor dimerization","volume":"289","author":"JE Maxson","year":"2014","journal-title":"J Biol Chem"},{"key":"pbio.3002883.ref066","article-title":"Optimization of therapeutic antibodies for reduced self-association and non-specific binding via interpretable machine learning","author":"EK Makowski","year":"2023","journal-title":"Nat Biomed Eng"},{"issue":"9","key":"pbio.3002883.ref067","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1110\/ps.051489405","article-title":"Aggregation of granulocyte-colony stimulating factor in vitro involves a conformationally altered monomeric state","volume":"14","author":"SW Raso","year":"2005","journal-title":"Protein Sci"},{"issue":"2","key":"pbio.3002883.ref068","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1021\/acs.molpharmaceut.1c00754","article-title":"Protein Engineering and HDX Identify Structural Regions of G-CSF Critical to Its Stability and Aggregation","volume":"19","author":"VE Wood","year":"2022","journal-title":"Mol Pharm"},{"issue":"5","key":"pbio.3002883.ref069","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1110\/ps.0235703","article-title":"Roles of conformational stability and colloidal stability in the aggregation of recombinant human granulocyte colony-stimulating factor","volume":"12","author":"EY Chi","year":"2003","journal-title":"Protein Sci"},{"issue":"3","key":"pbio.3002883.ref070","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1021\/acssynbio.1c00512","article-title":"Engineering Strategies to Overcome the Stability\u2013Function Trade-Off in Proteins","volume":"11","author":"M Teufl","year":"2022","journal-title":"ACS Synth Biol"},{"issue":"10","key":"pbio.3002883.ref071","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/nm.2958","article-title":"Interactions among HCLS1, HAX1 and LEF-1 proteins are essential for G-CSF\u2013triggered granulopoiesis","volume":"18","author":"J Skokowa","year":"2012","journal-title":"Nat Med"},{"issue":"11","key":"pbio.3002883.ref072","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1038\/s41375-021-01227-z","article-title":"Phenotypic characterization of leukemia-initiating stem cells in chronic myelomonocytic leukemia","volume":"35","author":"G Eisenwort","year":"2021","journal-title":"Leukemia"},{"issue":"6","key":"pbio.3002883.ref073","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1182\/blood.V69.6.1771.1771","article-title":"The effects of GM-CSF and G-CSF in promoting growth of clonogenic cells in acute myeloblastic leukemia","volume":"69","author":"E Vellenga","year":"1987","journal-title":"Blood"},{"issue":"6","key":"pbio.3002883.ref074","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1182\/blood.V68.6.1185.1185","article-title":"Clonogenic cells in acute myeloblastic leukemia","volume":"68","author":"JD Griffin","year":"1986","journal-title":"Blood"},{"issue":"5","key":"pbio.3002883.ref075","first-page":"378","article-title":"In vitro expression of colony-stimulating factor genes by human acute myeloblastic leukemia cells","volume":"16","author":"DC Young","year":"1988","journal-title":"Exp Hematol"},{"issue":"40","key":"pbio.3002883.ref076","doi-asserted-by":"crossref","first-page":"eabh3243","DOI":"10.1126\/sciadv.abh3243","article-title":"G-CSF secreted by mutant IDH1 glioma stem cells abolishes myeloid cell immunosuppression and enhances the efficacy of immunotherapy","volume":"7","author":"MS Alghamri","year":"2021","journal-title":"Sci Adv"},{"issue":"6","key":"pbio.3002883.ref077","doi-asserted-by":"crossref","first-page":"389","DOI":"10.4161\/cbt.19237","article-title":"Granulocyte-colony stimulating factor promotes proliferation, migration and invasion in glioma cells","volume":"13","author":"J Wang","year":"2012","journal-title":"Cancer Biol Ther"},{"issue":"6","key":"pbio.3002883.ref078","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1172\/JCI98224","article-title":"Granulocyte-CSF links destructive inflammation and comorbidities in obstructive lung disease","volume":"128","author":"E Tsantikos","year":"2018","journal-title":"J Clin Invest"},{"issue":"6","key":"pbio.3002883.ref079","first-page":"713","article-title":"High serum and synovial fluid granulocyte colony stimulating factor (G-CSF) concentrations in patients with rheumatoid arthritis","volume":"18","author":"H Nakamura","year":"2000","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"pbio.3002883.ref080","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1136\/annrheumdis-2012-202160","article-title":"Granulocyte colony stimulating factor exacerbates antineutrophil cytoplasmic antibody vasculitis","volume":"72","author":"SJ Freeley","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"pbio.3002883.ref081","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jcf.2005.12.004","article-title":"Increased serum concentration of G-CSF in cystic fibrosis patients with chronic Pseudomonas aeruginosa pneumonia","volume":"5","author":"P Jensen","year":"2006","journal-title":"J Cyst Fibros"},{"issue":"38","key":"pbio.3002883.ref082","doi-asserted-by":"crossref","first-page":"e17208","DOI":"10.1097\/MD.0000000000017208","article-title":"Serum cytokine, chemokine, and growth factor profiles and their modulation in inflammatory bowel disease","volume":"98","author":"ML Martinez-Fierro","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"pbio.3002883.ref083","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1189\/jlb.5A1116-489R","article-title":"A neutralizing anti\u2013G-CSFR antibody blocks G-CSF\u2013induced neutrophilia without inducing neutropenia in nonhuman primates","volume":"102","author":"K Scalzo-Inguanti","year":"2017","journal-title":"J Leukoc Biol"},{"issue":"1","key":"pbio.3002883.ref084","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s13238-017-0386-6","article-title":"In vitro-engineered non-antibody protein therapeutics","volume":"9","author":"R Simeon","year":"2018","journal-title":"Protein Cell"},{"issue":"1","key":"pbio.3002883.ref085","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1146\/annurev-chembioeng-061010-114300","article-title":"Delivery of molecular and nanoscale medicine to tumors: transport barriers and strategies","volume":"2","author":"VP Chauhan","year":"2011","journal-title":"Annu Rev Chem Biomol Eng"},{"key":"pbio.3002883.ref086","doi-asserted-by":"crossref","unstructured":"Shah DK, Betts AM, editors. Antibody biodistribution coefficients: inferring tissue concentrations of monoclonal antibodies based on the plasma concentrations in several preclinical species and human. MAbs; 2013;Taylor & Francis.","DOI":"10.4161\/mabs.23684"},{"key":"pbio.3002883.ref087","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.sbi.2021.03.011","article-title":"Expanding the versatility of natural and de novo designed coiled coils and helical bundles","volume":"68","author":"M ElGamacy","year":"2021","journal-title":"Curr Opin Struct Biol"},{"issue":"1","key":"pbio.3002883.ref088","doi-asserted-by":"crossref","first-page":"66","DOI":"10.5966\/sctm.2014-0145","article-title":"Concise review: engineering the fusion of cytokines for the modulation of immune cellular responses in cancer and autoimmune disorders","volume":"4","author":"S Ng","year":"2015","journal-title":"Stem Cells Transl Med"},{"key":"pbio.3002883.ref089","doi-asserted-by":"crossref","first-page":"e22882","DOI":"10.7554\/eLife.22882","article-title":"Synthekines are surrogate cytokine and growth factor agonists that compel signaling through non-natural receptor dimers","volume":"6","author":"I Moraga","year":"2017","journal-title":"Elife"},{"issue":"8","key":"pbio.3002883.ref090","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.cell.2022.02.025","article-title":"Facile discovery of surrogate cytokine agonists","volume":"185","author":"M Yen","year":"2022","journal-title":"Cell"},{"issue":"19","key":"pbio.3002883.ref091","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1016\/j.cell.2023.07.037","article-title":"Structure of the thrombopoietin-MPL receptor complex is a blueprint for biasing hematopoiesis","volume":"186","author":"N Tsutsumi","year":"2023","journal-title":"Cell"}],"container-title":["PLOS Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pbio.3002883","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T22:44:55Z","timestamp":1732661095000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pbio.3002883"}},"subtitle":[],"editor":[{"given":"Chaitan","family":"Khosla","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2024,11,26]]},"references-count":91,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pbio.3002883","relation":{},"ISSN":["1545-7885"],"issn-type":[{"value":"1545-7885","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,26]]}}}